Who owns INHIBRX BIOSCIENCES INC COM?
- Ticker: INBX
- CUSIP Number: 45720n103
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibrx Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibrx Biosciences stock
Who bought or sold INHIBRX BIOSCIENCES INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Viking Global Investors | 1.8M | $60M | 0% | Sep 2025 |
|
| Perceptive Advisors | 1.3M | $45M | 36% | Sep 2025 |
|
| Sanofi | 1.2M | $39M | 0% | Sep 2025 |
|
| HighTower Advisors | 872k | $29M | 0% | Sep 2025 |
|
| BlackRock | 685k | $23M | -6% | Sep 2025 |
|
| Vanguard Group | 595k | $20M | -1% | Sep 2025 |
|
| Sofinnova Ventures | 440k | $15M | -38% | Sep 2025 |
|
| Woodline Partners | 337k | $11M | -49% | Sep 2025 |
|
| Millennium Management | 298k | $10M | 8% | Sep 2025 |
|
| Partner Fund Management | 240k | $8.1M | -2% | Sep 2025 |
|
| Caligan Partners | 236k | $8.0M | 100% | Sep 2025 |
|
| Geode Capital Management | 222k | $7.5M | -2% | Sep 2025 |
|
| State Street Corporation | 204k | $6.9M | -1% | Sep 2025 |
|
| Readystate Asset Management | 170k | $5.7M | 534% | Sep 2025 |
|
| Kennedy Capital Management | 162k | $5.5M | -9% | Sep 2025 |
|
| Schonfeld Strategic Advisors | 97k | $3.3M | -37% | Sep 2025 |
|
| Northern Trust | 93k | $3.1M | -5% | Sep 2025 |
|
| Boothbay Fund Management | 79k | $2.7M | 179% | Sep 2025 |
|
| Caption Management | 73k | $2.5M | -63% | Sep 2025 |
|
| Jane Street | 63k | $2.1M | 225% | Sep 2025 |
|
| Citadel Advisors | 57k | $1.9M | 100% | Sep 2025 |
|
| SummitTX Capital | 54k | $1.8M | 100% | Sep 2025 |
|
| Bank of New York Mellon | 50k | $1.7M | -1% | Sep 2025 |
|
| Groupe la Francaise | 47k | $1.6M | -38% | Sep 2025 |
|
| Slotnik Capital | 41k | $1.4M | -78% | Sep 2025 |
|
| Wetherby Asset Management | 41k | $1.4M | 0% | Sep 2025 |
|
| FMR | 39k | $1.3M | 1% | Sep 2025 |
|
| Russell Investments | 38k | $1.3M | 27% | Sep 2025 |
|
| Arrowpoint Asset Management | 35k | $1.2M | -3% | Sep 2025 |
|
| Birchview Capital | 32k | $1.1M | -1% | Sep 2025 |
|
| Wellington Management Company | 30k | $1.0M | 100% | Sep 2025 |
|
| Credit Industriel Et Commercial | 29k | $975k | -55% | Sep 2025 |
|
| Acadian Asset Management | 28k | $957k | -76% | Sep 2025 |
|
| Morgan Stanley | 28k | $403k | 100% | Jun 2025 |
|
| Charles Schwab Investment Management | 28k | $936k | 0% | Sep 2025 |
|
| Marshall Wace | 27k | $918k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 26k | $875k | 51% | Sep 2025 |
|
| Meridian Wealth Advisors | 25k | $842k | 0% | Sep 2025 |
|
| Empirical Financial Services, LLC d/b/a Empirical Wealth Management | 23k | $761k | 0% | Sep 2025 |
|
| Susquehanna International | 21k | $694k | -11% | Sep 2025 |
|
| Alliancebernstein | 19k | $648k | -6% | Sep 2025 |
|
| Nuveen | 18k | $592k | -17% | Sep 2025 |
|
| Invesco | 18k | $592k | 30% | Sep 2025 |
|
| Mariner Wealth Advisors | 17k | $584k | 45% | Sep 2025 |
|
| Franklin Resources | 17k | $578k | -23% | Sep 2025 |
|
| Bridgeway Capital Management | 17k | $556k | 0% | Sep 2025 |
|
| Longwood Capital Partners | 16k | $552k | 100% | Sep 2025 |
|
| Ethic | 15k | $488k | -8% | Sep 2025 |
|
| Rhumbline Advisers | 14k | $463k | -4% | Sep 2025 |
|
| Jacobs Levy Equity Management | 14k | $462k | 100% | Sep 2025 |
|
| Barclays | 14k | $454k | -22% | Sep 2025 |
|
| Quantinno Capital Management | 12k | $398k | 100% | Sep 2025 |
|
| D. E. Shaw & Co | 12k | $389k | 100% | Sep 2025 |
|
| Belvedere Trading | 10k | $350k | 100% | Sep 2025 |
|
| UBS Group | 9.4k | $318k | -80% | Sep 2025 |
|
| Renaissance Technologies | 8.4k | $283k | 100% | Sep 2025 |
|
| HighVista Strategies | 7.6k | $257k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 7.6k | $256k | 18% | Sep 2025 |
|
| MetLife Investment Advisors | 7.4k | $250k | -3% | Sep 2025 |
|
| Dynamic Technology Lab Private | 7.4k | $249k | 100% | Sep 2025 |
|
| Arrowstreet Capital, Limited Partnership | 6.0k | $202k | 100% | Sep 2025 |
|
| AQR Capital Management | 6.0k | $202k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 4.8k | $163k | -25% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 4.1k | $139k | -17% | Sep 2025 |
|
| New York State Common Retirement Fund | 3.5k | $117k | 0% | Sep 2025 |
|
| Nbc Securities | 3.0k | $101k | 100% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 2.7k | $90k | 100% | Sep 2025 |
|
| China Universal Asset Management | 2.5k | $86k | -13% | Sep 2025 |
|
| Natixis | 2.0k | $67k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.9k | $64k | 72% | Sep 2025 |
|
| Ohio Pers | 1.2k | $40k | 100% | Sep 2025 |
|
| Tower Research Capital | 1.0k | $35k | -53% | Sep 2025 |
|
| Summit Investment Advisors | 853.00 | $29k | 0% | Sep 2025 |
|
| Legal & General Group | 768.00 | $26k | 0% | Sep 2025 |
|
| Sterling Capital Management | 625.00 | $21k | 155% | Sep 2025 |
|
| California State Teachers Retirement System | 568.00 | $19k | 100% | Sep 2025 |
|
| Mirae Asset Global Investments | 560.00 | $19k | 0% | Sep 2025 |
|
| Zurcher Kantonalbank | 498.00 | $17k | -32% | Sep 2025 |
|
| Royal Bank of Canada | 466.00 | $17k | -67% | Sep 2025 |
|
| Amalgamated Bank | 362.00 | $12k | 0% | Sep 2025 |
|
| Gf Fund Management | 307.00 | $10k | -14% | Sep 2025 |
|
| Sontag Advisory | 250.00 | $8.4k | 100% | Sep 2025 |
|
| FNY Investment Advisers | 250.00 | $3.0k | 0% | Jun 2025 |
|
| Us Bancorp | 217.00 | $7.3k | 100% | Sep 2025 |
|
| Versant Capital Management | 168.00 | $5.7k | 0% | Sep 2025 |
|
| CWM | 148.00 | $5.0k | 18% | Sep 2025 |
|
| GAMMA Investing | 139.00 | $4.7k | -10% | Sep 2025 |
|
| Advisor Group Holdings | 119.00 | $4.0k | 42% | Sep 2025 |
|
| Optiver Holding B.V. | 114.00 | $3.8k | 100% | Sep 2025 |
|
| Ubs Global Asset Management Americas | 110.00 | $3.7k | 100% | Sep 2025 |
|
| SRS Capital Advisors | 75.00 | $2.5k | 100% | Sep 2025 |
|
| Pnc Financial Services | 41.00 | $1.4k | 32% | Sep 2025 |
|
| EverSource Wealth Advisors | 40.00 | $1.3k | 82% | Sep 2025 |
|
| Farther Finance Advisors | 38.00 | $1.3k | 3700% | Sep 2025 |
|
| Rothschild Investment | 20.00 | $674.000000 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 13.00 | $437.999900 | 100% | Sep 2025 |
|
| NISA Investment Advisors | 11.00 | $370.000400 | 0% | Sep 2025 |
|
| Sunbelt Securities | 8.00 | $269.000000 | 100% | Sep 2025 |
|
| True Wealth Design | 4.00 | $135.000000 | 0% | Sep 2025 |
|
| Signature | 2.00 | $67.000000 | 0% | Sep 2025 |
|
Who sold out of Inhibrx Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ikarian Capital | Jun 2025 | 42k | $601k |
| Murchinson | Jun 2025 | 34k | $482k |
| Yakira Capital Management | Jun 2025 | 21k | $301k |
| JBF Capital | Jun 2025 | 21k | $299k |
| CI Private Wealth | Jun 2025 | 21k | $292k |
| Qube Research & Technologies | Jun 2025 | 20k | $284k |
| Hrt Financial | Jun 2025 | 20k | $282k |
| Fort Hoosac Management | Jun 2025 | 20k | $282k |
| Mark Asset Management | Jun 2025 | 17k | $243k |
| Bluefin Capital Management | Mar 2025 | 11k | $160k |
| Deutsche Bank Aktiengesellschaft | Jun 2025 | 4.7k | $67k |